[1]
“IMMUNOTHERAPY COMBINATIONS IN STAGE IV CANCER: SYNERGISTIC EFFECTS AND CLINICAL OUTCOMES”, FMHR, vol. 4, no. 1, pp. 94–107, Jan. 2026, Accessed: Jan. 13, 2026. [Online]. Available: https://fmhr.net/index.php/fmhr/article/view/1989